Holen Sie sich die Stockscreener-App
10.08
15.33%
1.34
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 4.1%Time to Buy? - MarketBeat
Teachers Retirement System of The State of Kentucky Cuts Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy - MSN
Ginkgo Bioworks joins project on cell-based disease treatment By Investing.com - Investing.com South Africa
Ginkgo Bioworks joins project on cell-based disease treatment - Investing.com
Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program - PR Newswire
Charles Schwab Investment Management Inc. Decreases Stock Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Investors Get Final OK Of $17.8M Settlement - Law360
Janus Henderson Group PLC Has $118,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading Down 5.5%What's Next? - MarketBeat
Verition Fund Management LLC Takes Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Lowers Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
BNP Paribas Financial Markets Makes New Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Long Term Trading Analysis for (DNA) - Stock Traders Daily
279,954 Shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Purchased by Jacobs Levy Equity Management Inc. - MarketBeat
Ginkgo Bioworks CFO Mark Dmytruk sells $7,146 in stock By Investing.com - Investing.com Australia
Ginkgo Bioworks executive sells $3,182 in stock - Investing.com India
Ginkgo Bioworks CFO Mark Dmytruk sells $7,146 in stock - Investing.com
Ginkgo Bioworks executive sells $3,182 in stock By Investing.com - Investing.com UK
Synthetic Biology Market Forecast: $61.6 Billion by 2029, Growing at 26.1% CAGR - GlobeNewswire Inc.
Concentric By Ginkgo and Texas A&M University Awarded USDA NIFA AFRI Grant to Conduct Genomic Animal Research to Prevent Zoonotic Disease Spillover - Marketscreener.com
Erste Asset Management GmbH Purchases Shares of 500,000 Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo (DNA) to Report Q2 Earnings: What's in the Cards? - MSN
PDT Partners LLC Invests $1.20 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Anchorage Capital Group L.L.C. Trims Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
AH Capital Management L.L.C. Trims Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Advances Collaboration with Merck to Improve Bio - GuruFocus.com
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results - GuruFocus.com
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Pre - GuruFocus.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Tao Capital Management LP - MarketBeat
US Bancorp DE Decreases Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q3 Loss, Tops Revenue Estimates - MSN
How To Trade (DNA) - Stock Traders Daily
Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Short Interest Update - MarketBeat
GSA Capital Partners LLP Has $979,000 Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Simply Wall St
Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Ginkgo cancels move to new South Boston lab, exits Cambridge office - MassLive.com
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2024 Earnings Call Transcript - MSN
Ginkgo Bioworks: Not Enough Progress (NYSE:DNA) - Seeking Alpha
Baillie Gifford & Co. Sells 131,067,285 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Reports Q3 Growth and Strategic Deals - TipRanks
Ginkgo nixes move to South Boston lab, will exit Cambridge sites. Here's what it means - NBC Boston
Ginkgo nixes move to South Boston lab, will exit Cambridge sites - The Business Journals
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing - Marketscreener.com
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings - Benzinga
Ginkgo Bioworks chief accounting officer sells $2,522 in stock - Investing.com India
Ginkgo Bioworks chief accounting officer sells $2,522 in stock By Investing.com - Investing.com Australia
(DNA) On The My Stocks Page - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Ginkgo Bioworks (DNA) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):